Search Results - "Ducassou, M"

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort by Cuzin, Lise, Pugliese, Pascal, Katlama, Christine, Bani-Sadr, Firouzé, Ferry, Tristan, Rey, David, Lourenco, Jeremy, Bregigeon, Sylvie, Allavena, Clotilde, Reynes, Jacques, Cabié, André

“…Abstract Objectives To analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor…”
Get full text

Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study by Ursenbach, Axel, Max, Vincent, Maurel, Marine, Bani-Sadr, Firouzé, Gagneux-Brunon, Amandine, Garraffo, Rodolphe, Ravaux, Isabelle, Robineau, Olivier, Makinson, Alain, Rey, David

“…Integrase strand transfer inhibitors (INSTIs) are increasingly used in patients living with HIV due to their safety, effectiveness and high genetic barrier…”
Get full text

Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort by Le Guillou, Adrien, Pugliese, Pascal, Raffi, François, Cabie, André, Cuzin, Lise, Katlama, Christine, Allavena, Clotilde, Drame, Moustapha, Cotte, Laurent, Bani-Sadr, Firouzé

“…Abstract Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of…”
Get full text

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study by Cuzin, Lise, Allavena, Clotilde, Cotte, Laurent, Delpierre, Cyrille, Huleux, Thomas, Palich, Romain, Delobel, Pierre, Raffi, François, Cabié, André

“…Abstract Objectives Even in an ‘optimal’ health system, patients’ characteristics may have an impact on their care. We investigated whether age, gender and…”
Get full text

EP-1222: Lung SBRT with Dynamic Tracking (DT) on the VERO (Brainlab-Mitsubishi) system by Jimenez, G, Gallocher, O, Chevelle, C, Dudouet, P, Franck, D, Latorzeff, I, Ducassou, M, Marre, D, Mathy, N, Mazurier, J, Navarro, P, Zarate, D

Get full text

EP-1573: 2D EPID-based in vivo dose reconstruction on head and neck cancers treated by intensity-modulated radiation therapy by Camilleri, J, Mazurier, J, Franck, D, Gallocher, O, Chevelle, C, Latorzeff, I, Jimenez, G, Ducassou, M, Marre, D, Mathy, N, Navarro, P, Zarate, D, Franceries, X

Get full text

EP-1513: 2D/3D EPID-based in-vivo dosimetry: Preliminary results by Camilleri, J, Mazurier, J, Franck, D, Ducassou, M, Gallocher, O, Latorzeff, I, Marre, D, Mathy, N, Zarate, D, Franceries, X

Get full text

Improved Outcomes With Iterative Local Treatments of Oligometastases in Sarcomas: A French Sarcoma Group Study by Falk, A, Moureau-Zabotto, L, Penel, N, Italiano, A, Bay, J, Sunyach, M, Ducassou, M, Olivier, T, Thyss, A, Thariat, J

Get full text

Quality control of the imaging and repositioning system of Vero accelerator (Brainlab-Mitsubishi) for stereotactic treatments by Ducassou, M, Marre, D, Mathy, N, Mazurier, J, Navarro, P, Zarate, D, Chevelle, C, Dudouet, P, Franck, D, Gallocher, O, Jimenez, G, Latorzeff, I

Get full text

Feedback on the project management of the accelerator VERO (Brainlab) for stereotactic treatments (SBRT): From project setup to clinical use by Zarate, D, Mazurier, J, Ducassou, M, Marre, D, Mathy, N, Navarro, P, Chevelle, C, Dudouet, P, Franck, D, Gallocher, O, Jimenez, G, Latorzeff, I

Get full text

2D/3D EPID-based in-vivo dose reconstruction for dynamic IMRT treatments by Camilleri, J, Mazurier, J, Franck, D, Gallocher, O, Chevelle, C, Latorzeff, I, Jimenez, G, Ducassou, M, Marre, D, Mathy, N, Navarro, P, Zarate, D, Franceries, X

Get full text

Two-dimensional dosimetric calibration of an electronic portal imaging device (EPID) for transit in vivo dose verification in external radiotherapy by Camilleri, J, Mazurier, J, Franck, D, Ducassou, M, Gallocher, O, Latorzeff, I, Marre, D, Mathy, N, Navarro, P, Zarate, D, Franceries, X

“…Introduction An algorithm to convert EPID signal (SEPID) into dose in water (DWATER) in transit conditions (i.e. with patient) is proposed and evaluated. This…”
Get full text

Validation and implementation of in vivo portal dosimetry for pelvic region treated by intensity modulated radiotherapy by Camilleri, J, Mazurier, J, Franck, D, Ducassou, M, Gallocher, O, Latorzeff, I, Marre, D, Mathy, N, Navarro, P, Zarate, D, Franceries, X

Get full text

Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men by Cotte, Laurent, Raffi, François, Gagneux‐Brunon, Amandine, Palich, Romain, Hoen, Bruno, Ferry, T., Boibieux, A., Miailhes, P., Valour, F., Schlienger, I., Lippmann, J., Braun, E., Longuet, C., Brochier, C., Degroodt, S., Breaud, S., Ceppi, C., Courjon, J., Cottalorda, J., Cottalorda, J., Demonchy, E., Durant, J., Durant, J., Etienne, C., Etienne, C., Fuzibet, J. G., Risso, K., Mondain, V., Oran, N., Pillet, S., Prouvost‐Keller, B., Brégigeon, S., Orticoni, M., Jaquet, I., Galie, S., Martinet, P., Ivanova, A., Debreux, C., Lions, C., Quertainmont, Y., Teicher, E., Vittecoq, D., Deradji, O., Barrail‐Tran, A., Consigny, P. H., Cessot, G., Goesch, J., Benabdelmoumen, G., Lanternier, F., Charlier, C., Rouzaud, C., Touam, F., Louisin, C., Duvivier, C., Lortholary, O., Danion, F., Biezunski, N., Delpierre, C., Piffaut, M., Merle de Boever, C., Montes, B., Montoya Ferrer, A., Tribout, V., Allavena, C., Biron, C., Brunet‐Cartier, C., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Sécher, S., Ferré, V., Grossi, O., Boucher, A., Huleux, T., Lafon‐Desmurs, B., Pradier, M., Robineau, O., Berger, J. L., Lebrun, D., Bani‐Sadr, F., Fischer, P., Partisani, M., Priester, M., Bernard‐Henry, C., Mautort, E., Frésard, A., Baud, O., Corbin, V., Casanova, S., Drobacheff‐Thiébaut, C., Muret, P., Abel, S., Césaire, R., Cuzin, L., Nguyen, D., Pierre‐François, S., Fabre, I., Curlier, E., Herrmann‐Storck, C.

“…Background & Aims HCV incidence still appears on the rise in HIV‐infected MSM in France. We assessed the incidence of HCV infection in HIV‐positive and in…”
Get full text

Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018 by Cotte, Laurent, Hocqueloux, Laurent, Lefebvre, Maeva, Pradat, Pierre, Bani-Sadr, Firouze, Huleux, Thomas, Poizot-Martin, Isabelle, Pugliese, Pascal, Rey, David, Cabié, André

“…Abstract Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV)…”
Get full text

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection by Gantner, Pierre, Cotte, Laurent, Allavena, Clotilde, Bani-Sadr, Firouzé, Huleux, Thomas, Duvivier, Claudine, Valantin, Marc-Antoine, Jacomet, Christine, Joly, Véronique, Chéret, Antoine, Pugliese, Pascal, Delobel, Pierre, Cabié, André, Rey, David

“…Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B…”
Get full text

Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era by Heard, Isabelle, Poizot-Martin, Isabelle, Potard, Valérie, Etienney, Isabelle, Crenn-Hebert, Catherine, Moore, Catherine, Touraine, Philippe, Cubie, Heather, Costagliola, Dominique

“…Background. Little is known about the type-specific prevalence of anal human papillomavirus (HPV) infection and risk factors for anal high-risk (HR) HPV…”
Get full text

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients by Poizot-Martin, Isabelle, Naqvi, Alissa, Obry-Roguet, Véronique, Valantin, Marc-Antoine, Cuzin, Lise, Billaud, Eric, Cheret, Antoine, Rey, David, Jacomet, Christine, Duvivier, Claudine, Pugliese, Pascal, Pradat, Pierre, Cotte, Laurent

“…Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral…”
Get full text

High Prevalence of Anal Human Papillomavirus–Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women by Heard, Isabelle, Etienney, Isabelle, Potard, Valérie, Poizot-Martin, Isabelle, Moore, Catherine, Lesage, Anne-Carole, Ressiot, Emmanuelle, Crenn-Hebert, Catherine, Fléjou, Jean-François, Cubie, Heather, Costagliola, Dominique, Darragh, Teresa M.

“…Background. Although human immunodeficiency virus (HIV)-infected women are at high risk for anal cancer, few data have been published on prevalence of and risk…”
Get full text

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination by Virlogeux, Victor, Zoulim, Fabien, Pugliese, Pascal, Poizot-Martin, Isabelle, Valantin, Marc-Antoine, Cuzin, Lise, Reynes, Jacques, Billaud, Eric, Huleux, Thomas, Bani-Sadr, Firouze, Rey, David, Frésard, Anne, Jacomet, Christine, Duvivier, Claudine, Cheret, Antoine, Hustache-Mathieu, Laurent, Hoen, Bruno, Cabié, André, Cotte, Laurent

“…HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval, resulting in…”
Get full text